Literature DB >> 2414252

Long-term culture and characterization of alloreactive T-cell infiltrates from renal needle biopsies.

C Miceli, R S Metzgar, M Chedid, F Ward, O J Finn.   

Abstract

Long-term T-cell lines have been established by culturing renal needle biopsies from kidney recipients undergoing graft rejection. These cultures are maintained in the presence of Interleukin 2, with weekly addition of irradiated donor lymphocytes as a source of antigen. The cells express T-cell markers, T3, T4, and T8, T-cell growth factor (IL2) receptor, and HLA-DR antigens. In one cell line, J2, the T4 and T8 antigens are found on two separate cell populations. This line is also shown to specifically kill Epstein Barr Virus transformed donor cells. This cytotoxicity is directed against HLA-B35 determinant and has been maintained in vitro for over 6 months.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2414252     DOI: 10.1016/0198-8859(85)90237-x

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  4 in total

Review 1.  In vitro assessment of FK 506 immunosuppressive activity in transplant patients.

Authors:  A Zeevi; R Venkataramanan; V Warty; G Eiras; M Woan; K Abu-Elmagd; M Alessiani; A Jain; A J Demetris; T Zerbe
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

2.  Development and characterisation of T lymphocyte lines from human small intestinal biopsies.

Authors:  D Kelleher; M F Kagnoff
Journal:  Gut       Date:  1989-04       Impact factor: 23.059

3.  Dynamics of allospecific T lymphocyte infiltration in vascularized human allografts.

Authors:  J J Fung; A Zeevi; B Markus; T R Zerbe; R J Duquesnoy
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

4.  Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells.

Authors:  D L Barnd; M S Lan; R S Metzgar; O J Finn
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.